LW News & Events

Lamb Weston reported a Q3 EPS beat of 12c, driven by stronger-than-expected North American performance that offset international weakness, interest expense, and tax benefits, JPMorgan tells investors in a research note. The company, whose report was "better than feared," narrowed and raised the midpoint of its annual EBITDA guidance, reflecting a stabilizing North American market and well-understood international pressures, with shares showing volatility despite a constructively received print, the firm says. JPMorgan retains a Neutral rating on the shares.

Consensus $6.53B. Narrows adjusted EBITDA view $1.08B-$1.14B from $1B-$1.2B. Sees cash used for capex $400M. The company said, "The Company's net sales guidance includes an approximate 1.8% benefit from an anticipated favorable foreign currency translation. The guidance also reflects the Company's current assessment of the anticipated impact of enacted tariffs by the U.S. and other countries but does not include potential effects of evolving trade policies or the potential for refunds, if any, relating to legal challenges or policy reversals. The guidance range takes into account the current expectation for ongoing disruption in certain markets in the Middle East. In addition, the fiscal 2026 outlook includes the contribution of a 53rd week in the fiscal period, which occurs in the fourth quarter of fiscal 2026."

Reports Q3 revenue $1.56B, consensus $1.49B. "Driven by continued solid performance in our North America segment, we delivered another quarter in line with our expectations," said Mike Smith, Lamb Weston president and CEO. "Our team's disciplined execution of our Focus to Win strategy continues to strengthen Lamb Weston and position us to drive long-term shareholder value. We are taking proactive steps to better align supply and demand, and we are acting with urgency to navigate the competitive international environment. Our focus on operational rigor and cost discipline continues to drive strong productivity, and we now expect to exceed our cost reduction target of at least $250 million by fiscal year-end 2028."

Notable companies reporting before tomorrow's open, with earnings consensus, include Cal-Maine (CALM), consensus 76c... Conagra (CAG), consensus 41c... Lamb Weston (LW), consensus 51c.